文献检索，用中文搜 PubMed

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

核心技术专利：CN118964589B侵权必究

Whitmore W F, Smith A, Yagoda A, Cvitkovic S T, Golbey R

Recent Results Cancer Res. 1977(60):244-9. doi: 10.1007/978-3-642-81095-4_27.

Seminoma may occasionally be rapidly growing, aggressive, radioresistant, and chemotherapy-resistant tumor. 2. Alkylating agents have had the greatest number of trials and have produced the best response rates in the management of seminoma, but a wide range of other agents warrants trials. 3. Adjunct chemotherapy is a logical consideration in patients with stage II and stage III seminoma.

精原细胞瘤偶尔可能是生长迅速、侵袭性强、对放疗和化疗耐药的肿瘤。2. 烷化剂进行的试验数量最多，在精原细胞瘤的治疗中产生了最佳缓解率，但其他多种药物也值得进行试验。3. 辅助化疗对于Ⅱ期和Ⅲ期精原细胞瘤患者来说是合理的考虑。

Recent Results Cancer Res. 1977(60):244-9. doi: 10.1007/978-3-642-81095-4_27.

Oncology. 1986;43(2):89-92. doi: 10.1159/000226341.

Gan No Rinsho. 1985 Apr;31(4):449-52.

Acta Radiol Oncol. 1984;23(4):263-70. doi: 10.3109/02841868409136022.

Cancer. 1974 May;33(5):1468-73. doi: 10.1002/1097-0142(197405)33:5<1468::aid-cncr2820330534>3.0.co;2-m.

Semin Urol. 1984 Nov;2(4):257-63.

J Urol. 1980 Nov;124(5):739-41. doi: 10.1016/s0022-5347(17)55636-0.

Semin Oncol. 1992 Apr;19(2):171-80.

Hinyokika Kiyo. 1984 Apr;30(4):513-7.

Clin Oncol (R Coll Radiol). 1990 Sep;2(5):249-53. doi: 10.1016/s0936-6555(05)80949-5.

Br J Cancer. 1985 Apr;51(4):467-72. doi: 10.1038/bjc.1985.67.

Whitmore W F, Smith A, Yagoda A, Cvitkovic S T, Golbey R

Recent Results Cancer Res. 1977(60):244-9. doi: 10.1007/978-3-642-81095-4_27.

Seminoma may occasionally be rapidly growing, aggressive, radioresistant, and chemotherapy-resistant tumor. 2. Alkylating agents have had the greatest number of trials and have produced the best response rates in the management of seminoma, but a wide range of other agents warrants trials. 3. Adjunct chemotherapy is a logical consideration in patients with stage II and stage III seminoma.